Amneal Said In Deal To Buy Epsilon Pharma, U.S. FDA-Approved Facility
This article was originally published in PharmAsia News
Executive Summary
Amneal Pharmaceuticals, a U.S.-based company with a research and development facility in India, reportedly is seeking to buy Epsilon Pharmaceuticals to give it a production facility in the country as well.